Introduction {#Sec1}
============

Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder following Alzheimer's disease. The main pathological feature of PD is the progressive loss of dopaminergic neurons in the Substantia Nigra pars compacta (SNpc), with the subsequent loss of dopamine (DA) in the striatum. Although much uncertainty still exists about the aetiology of PD, available evidence suggests the implication of numerous processes such as oxidative stress, mitochondrial dysfunction, inflammation and cell apoptosis. Specifically, the deleterious role of systemic inflammation in the onset and progression of PD is becoming evident, so that the interest in its study has increased in the last years^[@CR1]^.

In this sense, it is showed that dopaminergic neurons are more vulnerable to oxidative stress and pro-inflammatory cytokines because of their low levels of intracellular glutathione concentrations^[@CR2]^. Thus, a sustained systemic or brain inflammation involves activated microglia cells that secrete pro-inflammatory factors that damage neurons^[@CR3]^. At the same time, damaged neurons release toxic factors that recruit more glial cells, resulting in a fatal vicious cycle.

To clarify the implication of systemic inflammation in PD, different combinations of experimental animal models have been reported. The most commonly used animal model to approach this issue is based on the systemic administration of lipopolysaccharide (LPS). Extensive research has shown that this endotoxin, from gram-negative bacteria, activates microglia and produces a progressive and cumulative loss of dopaminergic neurons over time^[@CR4]^. For example, Qin et al. reported that LPS stimulates cells in the liver to produce TNF-α that is distributed in the blood to the brain to induce the synthesis of more TNF-α and, consequently, damaging dopaminergic neurons^[@CR5]^. In another study, the systemic administration of LPS was combined with the induction of ulcerative colitis by the oral ingestion of dextran sulphate sodium (DSS). The results from this work showed an exacerbation of LPS-induced damage in the nigrostriatal system^[@CR6]^. Furthermore, García-Domínguez and colleagues combined LPS with the 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP)-based model of PD. The obtained data reinforces the activation of microglial related-events together with the exacerbation of the dopaminergic neurodegeneration^[@CR7]^. Together with these observations, in our previous study, we showed an exacerbation of the dopaminergic neuronal death and the glial activation both in the SNpc and striatum when combining MPTP and DSS intoxications^[@CR8]^.

Despite the published literature, further analyses are yet required to elucidate in depth the cellular and molecular mechanisms triggered after a systemic insult in Parkinsonian mice. In the present study, we performed microarray and bioinformatics analysis to identify differentially expressed genes (DEGs) of mice treated with MPTP and/or DSS. This work's aim was to provide a better understanding of the effect of systemic inflammation on the development of PD.

Material and methods {#Sec2}
====================

Animals {#Sec3}
-------

The study was carried out on 16 three-months-old male C57BL/6J mice acquired from Charles River (Janvier, Le Genest Saint Isle, France). Animals were housed in a special room under regulated temperature (21 ± 1 °C) and 12-h light/dark cycles. The "Three R's principle" was carefully applied in our study. All procedures related to animal maintenance, care and experimentation were conducted in accordance with the European Community Council Directive (2010/63/UE) for animals to be used in preclinical studies, and were approved by the Institutional Committee on Animal Ethics of the University of Murcia (REGA ES300305440012).

Regimen of intoxication for DSS and MPTP {#Sec4}
----------------------------------------

Ulcerative colitis intoxication was induced for 8 days by oral administration of 2--2.5% of DSS (molecular weight, 36--50 kDa, MP Biomedicals LLC, OH, USA) in tap water. On day fourth, MPTP + HCl was intraperitoneal administrated with two injections at 2-h intervals in 1 day dissolved in 0.9% saline (15 mg/Kg, Sigma Aldrich, St Quentin). Mice were distributed in four experimental groups: (a) Control (n = 4), (b) DSS (n = 4), (c) MPTP (n = 5) and (d) MPTP + DSS (n = 5) (Fig. [1](#Fig1){ref-type="fig"}a). On day 8, mice were sacrificed by decapitation and brains were immediately removed and dissected into striatum and midbrain^[@CR8]^. Samples were correctly stored depending on their future use.Figure 1(**a**) Experimental design and mice distribution in the different groups. (**b**) Scheme of the main steps for obtaining and analyzing the results.

RNA extraction and purification for microarray analysis {#Sec5}
-------------------------------------------------------

Striatums were homogenated using QIAzol from the miRNeasy Mini Kit (Qiagen, Hilden, Germany) and stored at -- 80 °C until RNA extraction. Total RNA was extracted using the miRNeasy Mini Kit according to the manufacturer's instructions. RNA samples were quantitated on a NanoDrop 2000 (Thermo Fisher Scientific, Whaltham, MA). RNA quality was examined on an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA) using the RNA 6000 Nano Kit. RNA integrity numbers (RINs) of the samples ranged between 9.2 and 9.7. Samples were stored at -- 80 °C until microarray experiments.

RNA labelling, microarray hybridization and feature extraction {#Sec6}
--------------------------------------------------------------

RNA samples were thawed and labeled using Agilent Two Color Quick Amp Labeling and RNA Spike-In kits (Agilent), according to the manufacturer\'s protocol. Experimental samples were labeled with cyanine 5-CTP and used as tests. An Agilent Universal Mouse Reference RNA was labeled with cyanine 3-CTP and used as reference. Each of the labeled test cRNAs was mixed together with labeled reference cRNA. Then, mixes were hybridized onto SurePrint G3 Mouse Gene Expression v2 8 × 60 K microarrays targeting 27,122 Entrez Gene RNAs and 4,578 lncRNAs, using the Agilent Gene Expression Hybridization kit. After hybridization, the microarray slides were washed and scanned in an Agilent G2565CA DNA Microarray Scanner. Images were analyzed with the Agilent Feature Extraction software to automatically generate the datasets. Log~10~ ratios (test vs reference) were computed after normalization correction performed by linear and Lowess methods.

Analysis of the array expression {#Sec7}
--------------------------------

The raw data obtained was analyzed with the statistical language R^[@CR9]^ and limma package was used^[@CR10]^. Intra-array normalization was performed with the method of *Loess* and inter-array normalization with the *Aquantil* method. The expression levels of the signals belonging to the same gene were grouped, and the final expression value corresponds to the mean value, as described by Limma instructions. The comparisons between the groups was: D (DSS) vs Ctrl (Control); M (MPTP) vs Ctrl; MD (MPTP + DSS) vs Ctrl; D vs M; D vs MD and M vs MD. DEGs were obtained based on the false discovery rate (FDR, \< 0.05) for each comparison.

Enrichment analysis {#Sec8}
-------------------

The enrichment analyses for the up and down DEGs were carried out with gProfileR^[@CR11]^ that brings together enrichments from several databases, those of our interest were the annotations from Gene Ontology (GO) and Reactome. From the obtained GO annotations, we carefully summarize and remove redundant terms using Revigo^[@CR12]^. These results were illustrated in a network diagram using Cytoscape^[@CR13]^ for each ontology for comparisons: biological process (BP), molecular function (MF) and cellular component (CC) (Fig. [1](#Fig1){ref-type="fig"}b). The relationships between the nodes are based on the hierarchical association between the terms of the ontology. The brightness of the nodes refers to the level of significance.

Ethics approval and consent to participate {#Sec9}
------------------------------------------

Not applicable.

Consent for publication {#Sec10}
-----------------------

Not applicable.

Results {#Sec11}
=======

Differential gene expression profiles {#Sec12}
-------------------------------------

Firstly, normalization from the raw data (Fig. [2](#Fig2){ref-type="fig"}a.i) was made within (Fig. [2](#Fig2){ref-type="fig"}a.ii) and between groups (Fig. [2](#Fig2){ref-type="fig"}a.iii). To avoid any supervised analysis, volcano plots from all the comparisons between the experimental groups showed the distributions of the intensities (Fig. [2](#Fig2){ref-type="fig"}b). Moreover, samples from the four experimental groups were distinctly separated in the principal component analysis (PCA) plot, indicating a differential gene expression profile caused by both intoxications (Fig. [2](#Fig2){ref-type="fig"}c).Figure 2Validation of the DEGs profiles. (**a**) Normalization graphs from the raw data (i) was performed within (ii) and between (iii) groups. (**b**) Volcano plots comparing the levels of genes expressions between the experimental groups (i) DSS vs control; (ii) MPTP vs control; (iii) MPTP + DSS vs control; (iv) DSS vs MPTP; (v) DSS vs MPTP + DSS and (vi) MPTP vs MPTP + DSS. (**c**) PCA plot for the four experimental groups of interest (control, DSS, MPTP and MPTP + DSS).

Overall, a total of 2,413 genes were found to be differentially expressed, with an absolute fold change set at \> 2 and *p*-value \< 0.05 in all possible comparisons between the experimental groups \[see Supplementary file [1](#MOESM1){ref-type="media"}\]. Of the total DEGs, different number of genes were specifically identified based on the experimental group: DSS (132 genes), MPTP (345 genes) and MPTP + DSS (1,357 genes) compared with the control group, and MPTP compared with MPTP + DSS (281 genes) suggesting different effects in the striatum (Table [1](#Tab1){ref-type="table"}). Moreover, in the independent hierarchical clustering represented as heat-maps, it was confirmed the DEGs within and between groups \[see Supplementary file [1](#MOESM1){ref-type="media"}\], specifically exacerbated in the comparisons between MPTP + DSS and control groups.Table 1Total number of DEGs in the different experimental groups \[see Supplementary file [2](#MOESM1){ref-type="media"}\].ComparisonsTotal DEGsDown-regulatedUp-regulatedDSS vs ctrl1326369MPTP vs ctrl345150195MPTP + DSS vs ctrl1,357634723MPTP vs MPTP + DSS281124157

GO enrichment analysis {#Sec13}
----------------------

Based on the high amount of differential expressed genes between groups, we aimed to perform a functional enrichment analysis using g:GOSt from gProfiler which provides the most enriched GO terms together with other data sources (data shown in the Supplementary Files) associated with our gene lists.

Specifically, the data from the GO enrichment analysis is organized into three categories: (i) biological process, (ii) cellular component and (iii) molecular function. All the GO terms lists obtained in each category were summarize removing redundant terms using REVIGO. The output data was used to generate the GO-terms network graphs in Cytoscape. The setting threshold for the false discovery rate (FDR at 0.05).

Biological process {#Sec14}
------------------

Gene ontology enrichment analysis revealed different profiles depending on the experimental groups. Specifically, the results that concern biological process mainly involved GO terms for response to toxic substance/stimulus, detoxification and immune system but in different way depending on the experimental groups. Thus, up-regulated DEGs, related to response to toxic substance/stimulus, were found in groups treated with DSS (DSS and MPTP vs control; and, MPTP + DSS vs MPTP, Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). Interestingly, we found up-regulated DEGs related to detoxification mechanisms in animals treated with DSS compared to control mice (Table [2](#Tab2){ref-type="table"}, Fig. [3](#Fig3){ref-type="fig"}a) and MPTP + DSS, clearly observed when comparing MPTP + DSS vs MPTP (Table [3](#Tab3){ref-type="table"}, Fig. [4](#Fig4){ref-type="fig"}).Figure 3Summary of the main GO terms found for biological process in the comparisons for (**a**) DSS vs control and (**b**) MPTP vs control. The color of the circles help to better identify the groups of terms for specific processes: green for immune system process, pink for response to toxic substance, blue for apoptotic pathway and purple for response to unfolded protein. Figure 4Summary of the main GO terms found for biological process in the comparisons for MPTP + DSS vs control (**a**) and MPTP (**b**, i--iv). The color of the circles help to better identify the groups of terms for specific processes: green for immune system process (ii, **b**), pink for response to toxic substance/stimulus (ii, **b**), aquamarine for oxidative stress (iii), orange for cell activation (iv) and red for cell death (iv). Table 2The enriched GO terms for the up-regulated DEGs of DSS and MPTP vs control, respectively.GO TermDescriptionCorrected *p*-valueDEGs count**DSS vs control**GO:0098869Cellular oxidant detoxification1.08E−046GO:1990748Cellular detoxification1.10E−046GO:0098754Detoxification1.44E−046GO:0097237Cellular response to toxic substance1.00E−037GO:0015893Drug transport2.71E−036GO:0002376Immune system process8.49E−0317GO:0042493Response to drug3.23E−0210GO:0030097Hemopoiesis3.23E−029GO:0046501Protoporphyrinogen IX metabolic process3.23E−022GO:0048534Hematopoietic or lymphoid organ development4.23E−029**MPTP vs control**GO:0035966Response to topologically incorrect protein7.61E−0911GO:0006986Response to unfolded protein1.67E−0610GO:0035967Cellular response to topologically incorrect protein6.57E−058GO:0034620Cellular response to unfolded protein2.64E−047GO:0030968Endoplasmic reticulum unfolded protein response1.55E−036GO:0034976Response to endoplasmic reticulum stress6.22E−039GO:0002376Immune system process2.88E−0231GO:2001234Negative regulation of apoptotic signaling pathway3.29E−028GO:1904761Negative regulation of myofibroblast differentiation3.31E−022GO:1903573Negative regulation of response to endoplasmic reticulum stress4.80E−024 Table 3The enriched GO terms for the up-regulated DEGs of MPTP + DSS vs control and MPTP, respectively.GO TermDescriptionCorrected *p*-valueDEGs count**MPTP + DSS vs control**^a^GO:0070887Cellular response to chemical stimulus3.70E−13155GO:0098754Detoxification3.36E−1124GO:0002376Immune system process5.01E−11135GO:0006950Response to stress6.10E−11173GO:1990748Cellular detoxification1.07E−0921GO:0002682Regulation of immune system process1.65E−0986GO:0009605Response to external stimulus3.46E−09135GO:0006954Inflammatory response5.40E−0953GO:0050896Response to stimulus2.14E−08345GO:0097237Cellular response to toxic substance3.37E−0829GO:0080134Regulation of response to stress3.37E−0878GO:0009636Response to toxic substance3.37E−0845GO:0042127Regulation of cell population proliferation4.34E−0893GO:0006952Defense response4.34E−0888GO:0031347Regulation of defense response4.34E−0848GO:0098869Cellular oxidant detoxification4.52E−0818GO:0042592Homeostatic process7.16E−0898GO:0032502Developmental process1.14E−07238GO:0032101Regulation of response to external stimulus1.14E−0760GO:0001775Cell activation1.39E−0765GO:0048583Regulation of response to stimulus6.53E−07167GO:0001816Cytokine production8.61E−0749GO:0048856Anatomical structure development9.28E−07220**MPTP + DSS vs MPTP**^b^GO:0098754Detoxification5.56E−048GO:0002376Immune system process5.56E−0434GO:1990748Cellular detoxification2.93E−037GO:0055076Transition metal ion homeostasis8.11E−037GO:0097577Sequestering of iron ion9.03E−032GO:0051707Response to other organism9.03E−0321GO:0046916Cellular transition metal ion homeostasis9.03E−036GO:0046110Xanthine metabolic process9.03E−032GO:0098869Cellular oxidant detoxification9.03E−036GO:0043207Response to external biotic stimulus9.03E−0321GO:0009607Response to biotic stimulus9.03E−0321GO:0009605Response to external stimulus9.44E−0332See complete tables in the Supplementary Files.^a^Results shown for MPTP + DSS vs control with corrected *p*-value ≤ 1E-07.^b^Results shown for MPTP + DSS vs MPTP with corrected *p*-value ≤ 1E-03.

Moreover, the data revealed that genes related to immune system processes are up-regulated in DSS (Fig. [3](#Fig3){ref-type="fig"}a), MPTP (Fig. [3](#Fig3){ref-type="fig"}b) and MPTP + DSS (Fig. [4](#Fig4){ref-type="fig"}a) groups compared to the control group; and, when comparing MPTP + DSS with MPTP group (Fig. [4](#Fig4){ref-type="fig"}b). However, these genes are especially exacerbated when comparing MPTP + DSS with control and MPTP mice (Fig. [4](#Fig4){ref-type="fig"}a.ii and Table [3](#Tab3){ref-type="table"}). Together with the exacerbation of the immune system process, we also observed in this group oxidative stress processes (Fig. [4](#Fig4){ref-type="fig"}a.iii and Table [3](#Tab3){ref-type="table"}), cell activation and cell death (Fig. [4](#Fig4){ref-type="fig"}a.iii and Table [3](#Tab3){ref-type="table"}).

Cellular component {#Sec15}
------------------

Unlike in the category of biological process where in all groups came out significant up-regulation of the DEGs; in the cellular component were significantly observed only in the comparisons: DSS vs control, MPTP + DSS vs control and MPTP + DSS vs MPTP (Fig. [5](#Fig5){ref-type="fig"}). Interestingly, in the three comparisons (animals treated with DSS) the groups of genes related to haptoblobin-hemoglobin complex and the extracellular region stand out. In addition, when animals are treated together with MPTP (Fig. [5](#Fig5){ref-type="fig"}b and c.i, Table [4](#Tab4){ref-type="table"}), changes are also observed in the intracellular part.Figure 5Summary of the main GO terms obtained for cellular component in the comparisons for DSS vs control (**a**), MPTP + DSS vs MPTP (**b**) and MPTP + DSS vs control (**c**). The color of the circles correspond to different groups of annotations: purple for haptoblobin-hemoglobin complex, orange for extracellular region and green for intracellular part. Table 4The enriched GO terms for the DEGs of DSS and MPTP vs control, respectively.GO TermDescriptionCorrected *p*-valueDEGs count**DSS vs control**GO:0031838Haptoglobin--hemoglobin complex7.02E−074GO:0005833Hemoglobin complex1.46E−064GO:0005576Extracellular region1.86E−0420GO:0044445Cytosolic part2.26E−036GO:0036477Somatodendritic compartment2.77E−0311GO:0033093Weibel-palade body2.77E−032GO:0005615Extracellular space2.77E−0313GO:0044421Extracellular region part3.42E−0314**MPTP + DSS vs MPTP**GO:0005576Extracellular region2.42E−0639GO:0031838Haptoglobin--hemoglobin complex2.42E−064GO:0044421Extracellular region part3.43E−0631GO:0005615Extracellular space3.43E−0628GO:0005833Hemoglobin complex2.15E−033**MPTP + DSS vs MPTP**GO:0044421Extracellular region part6.98E−07104GO:0005615Extracellular space6.98E−0796GO:0005576Extracellular region1.73E−06122GO:0044444Cytoplasmic part1.73E−06302GO:0005737Cytoplasm3.19E−05360GO:0005829Cytosol1.01E−04147GO:0031838Haptoglobin--hemoglobin complex3.64E−045GO:0031012Extracellular matrix6.95E−0430GO:0009986Cell surface7.29E−0453GO:0008305Integrin complex2.41E−037GO:0044445Cytosolic part3.07E−0320GO:0098636Protein complex involved in cell adhesion3.58E−037GO:0005833Hemoglobin complex5.81E−034GO:0009897External side of plasma membrane7.66E−0330GO:0098552Side of membrane7.66E−0337

Molecular function {#Sec16}
------------------

Regarding molecular function GO annotations, we found terms from up-regulated DEGs mainly implicated in antioxidant activity and haptoglobin binding in the comparisons for DSS vs control, MPTP + DSS vs control and MPTP + DSS vs MPTP (Fig. [6](#Fig6){ref-type="fig"}, Table [5](#Tab5){ref-type="table"}).Figure 6Summary of the main GO terms obtained for molecular function in the comparisons for DSS vs control (**a**), MPTP + DSS vs control (**b**) and MPTP + DSS vs MPTP (**c**). Table 5The most significant enriched GO terms for the DEGs of DSS and MPTP vs control and MPTP + DSS vs MPTP.GO termDescriptionCorrected *p*-valueDEGs count**DSS vs control**^a^GO:0031720Haptoglobin binding9.59E−064GO:0005344Oxygen carrier activity3.37E−064GO:0019825Oxygen binding2.73E−054GO:0016209Antioxidant activity9.96E−055GO:0140104Molecular carrier activity1.63E−044GO:0004601Peroxidase activity2.19E−044GO:0031722Hemoglobin beta binding2.19E−042GO:0016684Oxidoreductase activity, acting on peroxide as acceptor2.52E−044GO:0031721Hemoglobin alpha binding1.02E−032GO:0030492Hemoglobin binding2.78E−032GO:0015106Bicarbonate transmembrane transporter activity2.78E−032GO:0005515Protein binding2.78E−0335GO:0005452Inorganic anion exchanger activity7.66E−032**MPTP + DSS vs control**^a^GO:0042802Identical protein binding7.99E−0797GO:0016209Antioxidant activity8.02E−0716GO:0005515Protein binding2.33E−06348GO:0030414Peptidase inhibitor activity1.78E−0522GO:0004857Enzyme inhibitor activity1.93E−0531GO:0061134Peptidase regulator activity4.69E−0523GO:0004866Endopeptidase inhibitor activity6.02E−0520GO:0061135Endopeptidase regulator activity1.28E−0420GO:0048037Cofactor binding3.16E−0437GO:0005488Binding4.53E−04460GO:0016491Oxidoreductase activity5.62E−0446GO:0003824Catalytic activity1.12E−03209GO:0030234Enzyme regulator activity1.12E−0350GO:0042803Protein homodimerization activity1.22E−0348GO:0004869Cysteine-type endopeptidase inhibitor activity1.35e−0310GO:0016722Oxidoreductase activity, oxidizing metal ions1.50E−036GO:0016684Oxidoreductase activity, acting on peroxide as acceptor1.75E−039GO:0005506Iron ion binding1.75E−0318GO:0004322Ferroxidase activity2.04E−035GO:0016724Oxidoreductase activity, oxidizing metal ions, oxygen as acceptor2.04E−035GO:1901567Fatty acid derivative binding2.53E−037GO:0031720Haptoglobin binding3.21E−034GO:0046906Tetrapyrrole binding3.49E−0316GO:0004165Dodecenoyl-coa delta-isomerase activity3.73E−033GO:0004601Peroxidase activity4.13E−038GO:0020037Heme binding6.13E−0315GO:0043177Organic acid binding6.15E−0317GO:0046914Transition metal ion binding6.71E−0350**MPTP + DSS vs MPTP**^a^GO:0031720Haptoglobin binding4.89E−043^a^Results shown with corrected *p*-value ≤ 1E−03.

Reactome enriched analysis {#Sec17}
--------------------------

The data obtained from the Reactome annotations divided the comparisons into different events in the same scenario (striatum level). Firstly, DSS compared to control stand out mechanisms related to heme dysfunction (as scavenging of heme from plasma or heme biosynthesis) possibly due to the bleeding produced by the DSS administration. Since free heme promotes the conversion of low density lipoproteins into cytotoxic products, make it toxic, it is also observed immune system processes up-regulation (Table [6](#Tab6){ref-type="table"}).Table 6Functional enriched Reactome annotations for all the comparisons.Reactome codeDescriptionCorrected *p*-valueDEGs count**DSS vs control**1247673Erythrocytes take up oxygen and release carbon dioxide7.33E−0851237044Erythrocytes take up carbon dioxide and release oxygen1.92E−0751480926O~2~/CO~2~ exchange in erythrocytes1.92E−0752168880Scavenging of heme from plasma8.25E−0552173782Binding and uptake of ligands by scavenger receptors1.52E−045189451Heme biosynthesis1.08E−022189445Metabolism of porphyrins2.54E−022216083Integrin cell surface interactions3.02E−023168256Immune system3.02E−0213**MPTP vs control**140342Apoptosis induced DNA fragmentation1.45E−0552559584Formation of senescence-associated heterochromatin foci (SAHF)4.68E−0552559586DNA damage/telomere stress induced senescence4.58E−03675153Apoptotic execution phase5.18E−035**MPTP + DSS vs control**168256Immune system1.48E−07111168249Innate immune system1.14E−06736798695Neutrophil degranulation2.75E−06471247673Erythrocytes take up oxygen and release carbon dioxide2.91E−044198933Immunoregulatory interactions between a lymphoid and a Non-lymphoid cell2.12E−03195686938Regulation of TLR by endogenous ligand2.12E−036804914Transport of fatty acids5.34E−034425397Transport of vitamins, nucleosides, and related molecules8.93E−0388978868Fatty acid metabolism1.33E−0219109582Hemostasis3.06E−0239216083Integrin cell surface interactions4.19E−02101236975Antigen processing-cross presentation4.45E−0272142688Synthesis of 5-eicosatetraenoic acids4.68E−023**MPTP + DSS vs MPTP**174577Activation of C3 and C57.20E−0331247673Erythrocytes take up oxygen and release carbon dioxide1.21E−0231480926O~2~/CO~2~ exchange in erythrocytes1.79E−0231237044Erythrocytes take up carbon dioxide and release oxygen1.79E−023

Regarding MPTP compared to control, we observed two main pathways: (i) programmed cell death by apoptosis induced DNA fragmentation, and (ii) cellular responses to external stimuli that implicated DNA damage/telomerase stress induced senescence (Table [6](#Tab6){ref-type="table"}).

On the other hand, the last events are exacerbated when comparing MPTP + DSS with both control and MPTP mice, which are the immune system processes. Specifically, it is observed: (i) the innate immune system response, with the up-regulation of the neutrophil degranulation and the toll-like receptor cascade (regulation of TLR by endogenous ligand) and, (ii) the adaptive immune system response, with the Class I MHC mediated antigen processing and presentation (antigen processing cross presentation) and immunoregulatory interactions between a lymphoid and a non-lymphoid cell (Table [6](#Tab6){ref-type="table"}).

Discussion {#Sec18}
==========

Prior work have remarked the involvement of systemic inflammation in the development of PD. The findings from the present work extend those published reports through a bioinformatics approach. We aimed to elucidate in depth the molecular and cellular mechanisms triggered after a systemic insult in the striatum of mice untreated and treated with MPTP. The importance of specifically studying the effect of both toxins in the striatum is based on previous data obtained by immunohistochemical techniques in which we observed exacerbation of the inflammatory events when combining both toxins^[@CR8]^.

The results from this study provide novel information about the DEGs in the striatum of mice intoxicated only with DSS. It is clear to observe the up-regulation of processes related to detoxification and inflammatory mechanisms (Fig. [3](#Fig3){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}) mainly triggered by the bleeding and lesion of the mucosal surface caused by the administration of DSS^[@CR14]^. This is the first study to our knowledge to describe the molecular and cellular mechanisms activated in the striatum after a local insult in the colon.

Otherwise, when comparing MPTP mice with the control group, we found biological processes related to the response to unfolded protein (Fig. [3](#Fig3){ref-type="fig"}b, Table [2](#Tab2){ref-type="table"}). Interestingly, these results are in accordance with the observations of Fornai and colleagues who described that the administration of MPTP reduces the protein degradation function of the striatal ubiquitin--proteasome system^[@CR15]^. Later on, it was added that this could lead the accumulation of unfolded proteins and consequently, activates stress-induced cell death mechanisms^[@CR16]^. Moreover, it was demonstrated that oxidative stress processes may participate in the formation of cross-linked protein aggregates^[@CR17]^. In these animals, we also noticed DEGs associated with an attempt to regulate negatively the apoptotic signalling pathway and positively the activation of the inflammatory response (Table [3](#Tab3){ref-type="table"}). Interestingly, the data from Reactome analysis showed annotations related to the execution of apoptosis mechanisms induced by DNA fragmentation and the induction of cellular senescence. These results are in line with those reported to another study that suggests that the nature and severity of DNA damage may determine the cellular response^[@CR18]^. More research is needed to clarify how is the interplay of both routes after a DNA insult^[@CR19]^.

Most notably were the observations that resulted from the comparison between MPTP + DSS and control animals. As this work indicates, we obtained an exacerbation of the up-regulated DEGs in all the analysis related to detoxification, oxidative stress and immune system processes.

Our results not only reinforce those results reported in the literature but also extend detailed information on the contribution of systemic inflammation to the progression of the neurodegeneration associated with Parkinson's disease. Although our aim was highly achieved, we are aware of some intrinsic limitations such as the number of animals used in this type of studies^[@CR20],[@CR21]^ or the focus in one brain area. The relevance of this lies in the contribution of novel and detailed information that describes different expression profiles that can be used as a guide for further and specific analysis. We advise that future work should evaluate upregulated pathways in different brain areas over time. In this way, we will be able to identify promising therapeutic targets that prevent the contribution of inflammatory processes in the progression of Parkinson's disease.

Conclusions {#Sec19}
===========

Altogether, we provide functional and comprehensive bioinformatics analyses of the deleterious effect of the systemic inflammation in the striatum of MPTP intoxicated mice. Interestingly, the data showed in this study describes a scenario that becomes more complex when combining both treatments. Thus, the processes related to inflammation and oxidative stress are exacerbated resulting in a significant up-regulation of the cell death mechanisms.
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